featured
Vemurafenib for Metastatic BRAF-Mutated Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
J. Clin. Oncol 2015 Oct 12;[EPub Ahead of Print], S Kopetz, J Desai, E Chan, JR Hecht, PJ O'Dwyer, D Maru, V Morris, F Janku, A Dasari, W Chung, JJ Issa, P Gibbs, B James, G Powis, KB Nolop, S Bhattacharya, L SaltzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.